Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

NJR unit builds 16 megawatts' worth of solar installations

By Eric Strauss
January 30, 2015 04:20 PM

CONTINUE READING

NGKF chosen as exclusive leasing agent for former Pfizer HQ

By Eric Strauss
January 30, 2015 11:27 AM

CONTINUE READING

advertisement

Hasbrouck Heights architecture firm secures 3-year NYC pact

By Emily Bader
January 30, 2015 12:21 PM

CONTINUE READING

Sitar Realty involved in several leases

By Eric Strauss
January 29, 2015 03:34 PM

CONTINUE READING

KeyBank adds execs to northern N.J. team

By Eric Strauss
January 29, 2015 03:22 PM

CONTINUE READING

Jersey City digital media company wraps up merger with advertising tech firm

By Eric Strauss
January 29, 2015 10:55 AM

CONTINUE READING

Logistics company signs lease for South Brunswick distribution center

By Eric Strauss
January 29, 2015 12:00 PM

CONTINUE READING

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:

Pfizer top pharma firm on Fortune 500

By

Back to Top Comments Email Print

Latest News

advertisement

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.

Meanwhile:

  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

Share This Story On:
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement
follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement
Pfizer top pharma firm on Fortune 500 | NJBIZ

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top